|
Clinical Characteristics for Total Study Group |
|||
| Group A (n = 24) |
Group B (n = 18) |
Control Group (n = 19) |
|
|
|
|||
| Age (years) |
56 ± 11 |
61 ± 13 |
59 ± 12 |
| Male gender |
14(58%) |
10(56%) |
10(57%) |
| Smokers |
15(62.5%) |
11(62%) |
11(62.5%) |
| Systolic Blood Pressure (mmHg) |
145 ± 20 |
143 ± 22 |
139 ± 25 |
| Diastolic Blood Pressure (mmHg) |
80 ± 10 |
82 ± 11 |
80 ± 11 |
| Known hypertension (160/90 mmHg) |
8 (33.4%) |
6 (34%) |
7(35%) |
| Lone AF |
11(45.8%) |
8 (44.2%) |
- |
| Coronary artery Disease |
5(20.8%) |
4(22%) |
5(22.8%) |
| Diabetes mellitus |
6(25%) |
4(22%) |
4(22.3%) |
| Hct(%) |
45.8 ± 3.9 |
44.9 ± 4.2 |
45 ± 3.6 |
| Hb(g/dl) |
15.3 ± 1.34 |
14.8 ± 2.9 |
15.2 ± 3.1 |
| Fbg (mg/dl) |
229.9 ± 27.0 |
237 ± 37.6 |
227 ± 26 |
| P value: non significant (NS) |
|||
| Echocardiographic data for Both Groups pre cardioversion |
|||
|
|
|||
| Group A |
Group B |
||
|
|
|||
| Left atrial diameter(cm) |
4.2 ± 0.6 |
4.0 ± 0.8 |
|
| Left ventricular diastolic dimension (cm) |
5.2 ± 1.0 |
5.0 ± 0.9 |
|
| Left ventricular systolic dimension (cm) |
4.1 ± 0.5 |
4.0 ± 0.8 |
|
|
P value: non significant (NS) | |||
Hatzinikolaou-Kotsakou et al. Thrombosis Journal 2005 3:2 doi:10.1186/1477-9560-3-2 |
|||